Vaccines: What Kidney Patients Need to Know
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
According to a 2024 World Health Organization study, over the last 50 years vaccines have saved over 154 million lives worldwide from over 20 life threatening diseases. As vaccines are facing skepticism, we are here to cut through the noise and lay out the facts as to why staying up-to-date on vaccinations is especially important for kidney patients.
This episode is sponsored by Moderna.
In today's episode we heard from:
Mary Baliker has been a dedicated healthcare advocate for the past 40 years, and is involved in several kidney initiatives regionally, nationally and globally. Mary was diagnosed with a rare kidney disease at the age of nine and since then has undergone hemodialysis and received four kidney transplants. As a result of this life-long journey, Mary cherishes her life and possesses a strong desire to help improve the healthcare experience, health outcomes and quality of life for patients with kidney disease. In addition to publishing multiple peer reviewed articles related to the kidney patient experience, Mary is the author of Maria Never Gives Up, a story written to help children and families facing chronic illnesses. Her book is distributed across transplant and dialysis centers nationwide and is available for purchase online
William Werbel, MD, PhD is a transplant infectious diseases physician and scientist at Johns Hopkins focused on optimizing protection against infections in immunocompromised persons. He completed clinical and research fellowship in infectious diseases at Johns Hopkins following MD training at the University of Michigan and internal medicine residency and chief residency at the Northwestern Feinberg School of Medicine. He is the current Associate Director for Epidemiology and Quantitative Sciences in the Johns Hopkins Transplant Research Center and principal investigator of the national Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) cohort study. He receives NIH funding to study the landscape of infections in transplant recipients and evaluate the real-world impact of vaccination using a combination of epidemiological and laboratory approaches.
Additional Resources:
Vaccines for CKD Patients
Vaccine Integrity Project
IDSA Immunization Resources
Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) Study
Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.